Dysregulation of CDK8 and Cyclin C in tumorigenesis

Journal of Genetics and Genomics

Volumn 38, Issue 10, 2011, Pages 439-452

  Xu, Wu ^a   Ji, Jun Yuan ^b  

^a UNIVERSITY OF LOUISIANA AT LAFAYETTE   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

CDK8; MD simulation; Mediator complex; Transcription; Tumorigenesis

Indexed keywords

CYCLIN C; CYCLIN DEPENDENT KINASE 8;

CARCINOGENESIS; COLORECTAL CANCER; DROSOPHILA; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; IN VIVO STUDY; MELANOMA; NONHUMAN; PHYLOGENY; PROTEIN DOMAIN; PROTEIN FUNCTION; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN C; CYCLIN-DEPENDENT KINASE 8; DROSOPHILA MELANOGASTER; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDIATOR COMPLEX; MOLECULAR SEQUENCE DATA; NEOPLASMS; PHYLOGENY; PROTEIN CONFORMATION; RNA POLYMERASE II; TRANSCRIPTION, GENETIC;

EUKARYOTA;

EID: 80054949798     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2011.09.002     Document Type: Review

References (109)

1. Akoulitchev S., Chuikov S., Reinberg D. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 2000, 407:102-106.
2. Barette C., Jariel-Encontre I., Piechaczyk M., Piette J. Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity. Oncogene 2001, 20:551-562.
3. Baumli S., Lolli G., Lowe E.D., Troiani S., Rusconi L., Bullock A.N., Debreczeni J.E., Knapp S., Johnson L.N. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. EMBO J. 2008, 27:1907-1918.
4. Bernecky C., Grob P., Ebmeier C.C., Nogales E., Taatjes D.J. Molecular architecture of the human Mediator-RNA polymerase II-TFIIF assembly. PLoS Biol. 2011, 9:e1000603.
5. Bjorklund S., Gustafsson C.M. The yeast Mediator complex and its regulation. Trends Biochem. Sci. 2005, 30:240-244.
6. Bourbon H.M. Comparative genomics supports a deep evolutionary origin for the large, four-module transcriptional mediator complex. Nucleic Acids Res. 2008, 36:3993-4008.
7. Bourbon H.M., Aguilera A., Ansari A.Z., Asturias F.J., Berk A.J., Bjorklund S., Blackwell T.K., Borggrefe T., Carey M., Carlson M., Conaway J.W., Conaway R.C., Emmons S.W., Fondell J.D., Freedman L.P., Fukasawa T., Gustafsson C.M., Han M., He X., Herman P.K., Hinnebusch A.G., Holmberg S., Holstege F.C., Jaehning J.A., Kim Y.J., Kuras L., Leutz A., Lis J.T., Meisterernest M., Näär A.M., Nasmyth K., Parvin J.D., Ptashne M., Reinberg D., Ronne H., Sadowski I., Sakurai H., Sipiczki M., Sternberg P.W., Stillman D.J., Strich R., Struhl K., Svejstrup J.Q., Tuck S., Winston F., Roeder R.G., Kornberg R.D. A unified nomenclature for protein subunits of mediator complexes linking transcriptional regulators to RNA polymerase II. Mol. Cell 2004, 14:553-557.
8. Brewster C.D., Birkenheuer C.H., Vogt M.B., Quackenbush S.L., Rovnak J. The retroviral cyclin of walleye dermal sarcoma virus binds cyclin-dependent kinases 3 and 8. Virology 2011, 409:299-307.
9. Brown N.R., Noble M.E., Endicott J.A., Johnson L.N. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell Biol. 1999, 1:438-443.
10. Carlson M. Genetics of transcriptional regulation in yeast: connections to the RNA polymerase II CTD. Annu. Rev. Cell Dev. Biol. 1997, 13:1-23.
11. Carrera I., Janody F., Leeds N., Duveau F., Treisman J.E. Pygopus activates Wingless target gene transcription through the mediator complex subunits Med12 and Med13. Proc. Natl. Acad. Sci. USA 2008, 105:6644-6649.
12. Casamassimi A., Napoli C. Mediator complexes and eukaryotic transcription regulation: an overview. Biochimie 2007, 89:1439-1446.
13. Chattopadhyay I., Singh A., Phukan R., Purkayastha J., Kataki A., Mahanta J., Saxena S., Kapur S. Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India. Mutat. Res. 2010, 696:130-138.
14. Conaway R.C., Conaway J.W. Function and regulation of the Mediator complex. Curr. Opin. Genet. Dev. 2011, 21:225-230.
15. Conaway R.C., Sato S., Tomomori-Sato C., Yao T., Conaway J.W. The mammalian Mediator complex and its role in transcriptional regulation. Trends Biochem. Sci. 2005, 30:250-255.
16. Ding N., Tomomori-Sato C., Sato S., Conaway R.C., Conaway J.W., Boyer T.G. MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression. J. Biol. Chem. 2009, 284:2648-2656.
17. Ding N., Zhou H., Esteve P.O., Chin H.G., Kim S., Xu X., Joseph S.M., Friez M.J., Schwartz C.E., Pradhan S., Boyer T.G. Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. Mol. Cell 2008, 31:347-359.
18. Doonan J.H., Kitsios G. Functional evolution of cyclin-dependent kinases. Mol. Biotechnol. 2009, 42:14-29.
19. Ebmeier C.C., Taatjes D.J. Activator-Mediator binding regulates Mediator-cofactor interactions. Proc. Natl. Acad. Sci. USA 2010, 107:11283-11288.
20. Elmlund H., Baraznenok V., Lindahl M., Samuelsen C.O., Koeck P.J., Holmberg S., Hebert H., Gustafsson C.M. The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II. Proc. Natl. Acad. Sci. USA 2006, 103:15788-15793.
21. Feinberg A.P., Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer 2004, 4:143-153.
22. Firestein R., Hahn W.C. Revving the Throttle on an oncogene: CDK8 takes the driver seat. Cancer Res. 2009, 69:7899-7901.
23. Firestein R., Shima K., Nosho K., Irahara N., Baba Y., Bojarski E., Giovannucci E.L., Hahn W.C., Fuchs C.S., Ogino S. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival. Int. J. Cancer 2010, 126:2863-2873.
24. Firestein R., Bass A.J., Kim S.Y., Dunn I.F., Silver S.J., Guney I., Freed E., Ligon A.H., Vena N., Ogino S., Chheda M.G., Tamayo P., Finn S., Shrestha Y., Boehm J.S., Jain S., Bojarski E., Mermel C., Barretina J., Chan J.A., Baselga J., Tabernero J., Root D.E., Fuchs C.S., Loda M., Shivdasani R.A., Meyerson M., Hahn W.C. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 2008, 455:547-551.
25. Fisher R.P. Secrets of a double agent: CDK7 in cell-cycle control and transcription. J. Cell Sci. 2005, 118:5171-5180.
26. Fryer C.J., White J.B., Jones K.A. Mastermind recruits CycC: CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol. Cell 2004, 16:509-520.
27. Galamb O., Sipos F., Molnar B., Szoke D., Spisak S., Tulassay Z. Evaluation of malignant and benign gastric biopsy specimens by mRNA expression profile and multivariate statistical methods. Cytometry B Clin. Cytom. 2007, 72:299-309.
28. Galbraith M.D., Donner A.J., Espinosa J.M. CDK8: a positive regulator of transcription. Transcription 2010, 1:4-12.
29. Gobert V., Osman D., Bras S., Auge B., Boube M., Bourbon H.M., Horn T., Boutros M., Haenlin M., Waltzer L. A genome-wide RNA interference screen identifies a differential role of the mediator CDK8 module subunits for GATA/RUNX-activated transcription in Drosophila. Mol. Cell. Biol. 2010, 30:2837-2848.
30. Greene D.M., Hsu D.W., Pears C.J. Control of cyclin C levels during development of Dictyostelium. PLoS One 2010, 5:e10543.
31. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
32. Hahn S. Structure and mechanism of the RNA polymerase II transcription machinery. Nat. Struct. Mol. Biol. 2004, 11:394-403.
33. Hallberg M., Polozkov G.V., Hu G.Z., Beve J., Gustafsson C.M., Ronne H., Bjorklund S. Site-specific Srb10-dependent phosphorylation of the yeast Mediator subunit Med2 regulates gene expression from the 2-microm plasmid. Proc. Natl. Acad. Sci. USA 2004, 101:3370-3375.
34. Hallstrom T.C., Mori S., Nevins J.R. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 2008, 13:11-22.
35. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
36. Hengartner C.J., Myer V.E., Liao S.M., Wilson C.J., Koh S.S., Young R.A. Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol. Cell 1998, 2:43-53.
37. Hoffmans R., Stadeli R., Basler K. Pygopus and legless provide essential transcriptional coactivator functions to armadillo/beta-catenin. Curr. Biol. 2005, 15:1207-1211.
38. Honda R., Lowe E.D., Dubinina E., Skamnaki V., Cook A., Brown N.R., Johnson L.N. The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles. EMBO J. 2005, 24:452-463.
39. Huang K., Ferrin-O'Connell I., Zhang W., Leonard G.A., O'Shea E.K., Quiocho F.A. Structure of the Pho85-Pho80 CDK-cyclin complex of the phosphate-responsive signal transduction pathway. Mol. Cell 2007, 28:614-623.
40. Hughes T.A., Brady H.J. E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisation. Biochem. Biophys. Res. Commun. 2005, 329:1267-1274.
41. Janody F., Martirosyan Z., Benlali A., Treisman J.E. Two subunits of the Drosophila mediator complex act together to control cell affinity. Development 2003, 130:3691-3701.
42. Ji J.Y., Dyson N.J. Interplay between Cyclin-dependent Kinases and E2F-dependent Transcription. Cell Cycle Deregulation in Cancer 2010, 23-41. Springer Science. G.H. Enders (Ed.).
43. Kapoor A., Goldberg M.S., Cumberland L.K., Ratnakumar K., Segura M.F., Emanuel P.O., Menendez S., Vardabasso C., Leroy G., Vidal C.I., Polsky D., Osman I., Garcia B.A., Hernando E., Bernstein E. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 2010, 468:1105-1109.
44. Kaur M., Velmurugan B., Tyagi A., Agarwal C., Singh R.P., Agarwal R. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling. Neoplasia 2010, 12:415-424.
45. Kim M.Y., Han S.I., Lim S.C. Roles of cyclin-dependent kinase 8 and beta-catenin in the oncogenesis and progression of gastric adenocarcinoma. Int. J. Oncol. 2011, 38:1375-1383.
46. Kim S., Xu X., Hecht A., Boyer T.G. Mediator is a transducer of Wnt/beta-catenin signaling. J. Biol. Chem. 2006, 281:14066-14075.
47. Kim Y.J., Lis J.T. Interactions between subunits of Drosophila Mediator and activator proteins. Trends Biochem. Sci. 2005, 30:245-249.
48. Kinzler K.W., Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997, 386:761-763.
49. Knuesel M.T., Taatjes D.J. Mediator and post-recruitment regulation of RNA polymerase II. Transcription 2011, 2:28-31.
50. Knuesel M.T., Meyer K.D., Bernecky C., Taatjes D.J. The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. Genes Dev. 2009, 23:439-451.
51. Knuesel M.T., Meyer K.D., Donner A.J., Espinosa J.M., Taatjes D.J. The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator. Mol. Cell. Biol. 2009, 29:650-661.
52. Kornberg R.D. Mediator and the mechanism of transcriptional activation. Trends Biochem. Sci. 2005, 30:235-239.
53. Krasley E., Cooper K.F., Mallory M.J., Dunbrack R., Strich R. Regulation of the oxidative stress response through Slt2 p-dependent destruction of cyclin C in Saccharomyces cerevisiae. Genetics 2006, 172:1477-1486.
54. Larochelle S., Chen J., Knights R., Pandur J., Morcillo P., Erdjument-Bromage H., Tempst P., Suter B., Fisher R.P. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity. EMBO J. 2001, 20:3749-3759.
55. Leclerc V., Tassan J.P., O'Farrell P.H., Nigg E.A., Leopold P. Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II. Mol. Biol. Cell 1996, 7:505-513.
56. Li H., Lahti J.M., Kidd V.J. Alternatively spliced cyclin C mRNA is widely expressed, cell cycle regulated, and encodes a truncated cyclin box. Oncogene 1996, 13:705-712.
57. Liu J., Kipreos E.T. Evolution of cyclin-dependent kinases (CDKs) and CDK-activating kinases (CAKs): differential conservation of CAKs in yeast and metazoa. Mol. Biol. Evol. 2000, 17:1061-1074.
58. Liu L.X., Liu Z.H., Jiang H.C., Zhang W.H., Qi S.Y., Hu J., Wang X.Q., Wu M. Gene expression profiles of hepatoma cell line HLE. World J. Gastroenterol. 2003, 9:683-687.
59. Liu L.X., Jiang H.C., Liu Z.H., Zhu A.L., Zhou J., Zhang W.H., Wang X.Q., Wu M. Gene expression profiles of hepatoma cell line BEL-7402. Hepatogastroenterology 2003, 50:1496-1501.
60. Liu Y., Kung C., Fishburn J., Ansari A.Z., Shokat K.M., Hahn S. Two cyclin-dependent kinases promote RNA polymerase II transcription and formation of the scaffold complex. Mol. Cell. Biol. 2004, 24:1721-1735.
61. Lolli G., Lowe E.D., Brown N.R., Johnson L.N. The crystal structure of human CDK7 and its protein recognition properties. Structure 2004, 12:2067-2079.
62. Loncle N., Boube M., Joulia L., Boschiero C., Werner M., Cribbs D.L., Bourbon H.M. Distinct roles for Mediator Cdk8 module subunits in Drosophila development. EMBO J. 2007, 26:1045-1054.
63. Malik S., Roeder R.G. Dynamic regulation of pol II transcription by the mammalian Mediator complex. Trends Biochem. Sci. 2005, 30:256-263.
64. Malik S., Guermah M., Yuan C.X., Wu W., Yamamura S., Roeder R.G. Structural and functional organization of TRAP220, the TRAP/mediator subunit that is targeted by nuclear receptors. Mol. Cell. Biol. 2004, 24:8244-8254.
65. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-166.
66. Martin E.S., Tonon G., Sinha R., Xiao Y., Feng B., Kimmelman A.C., Protopopov A., Ivanova E., Brennan C., Montgomery K., Kucherlapati R., Bailey G., Redston M., Chin L., DePinho R.A. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. Cancer Res. 2007, 67:10736-10743.
67. Martinez A.M., Afshar M., Martin F., Cavadore J.C., Labbe J.C., Doree M. Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity. EMBO J. 1997, 16:343-354.
68. McAloose D., Newton A.L. Wildlife cancer: a conservation perspective. Nat. Rev. Cancer 2009, 9:517-526.
69. Meyer K.D., Donner A.J., Knuesel M.T., York A.G., Espinosa J.M., Taatjes D.J. Cooperative activity of cdk8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3. EMBO J. 2008, 27:1447-1457.
70. Mitra A.P., Almal A.A., George B., Fry D.W., Lenehan P.F., Pagliarulo V., Cote R.J., Datar R.H., Worzel W.P. The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer. BMC Cancer 2006, 6:159.
71. Mittler G., Kremmer E., Timmers H.T., Meisterernst M. Novel critical role of a human Mediator complex for basal RNA polymerase II transcription. EMBO Rep. 2001, 2:808-813.
72. Morris E.J., Ji J.Y., Yang F., Di Stefano L., Herr A., Moon N.S., Kwon E.J., Haigis K.M., Näär A.M., Dyson N.J. E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 2008, 455:552-556.
73. Mukhopadhyay A., Kramer J.M., Merkx G., Lugtenberg D., Smeets D.F., Oortveld M.A., Blokland E.A., Agrawal J., Schenck A., van Bokhoven H., Huys E., Schoenmakers E.F., van Kessel A.G., van Nouhuys C.E., Cremers F.P. CDK19 is disrupted in a female patient with bilateral congenital retinal folds, microcephaly and mild mental retardation. Hum. Genet. 2010, 128:281-291.
74. Myers L.C., Kornberg R.D. Mediator of transcriptional regulation. Annu. Rev. Biochem. 2000, 69:729-749.
75. Näär A.M., Lemon B.D., Tjian R. Transcriptional coactivator complexes. Annu. Rev. Biochem. 2001, 70:475-501.
76. Näär A.M., Taatjes D.J., Zhai W., Nogales E., Tjian R. Human CRSP interacts with RNA polymerase II CTD and adopts a specific CTD-bound conformation. Genes Dev. 2002, 16:1339-1344.
77. Nagaraj S.H., Reverter A. A Boolean-based systems biology approach to predict novel genes associated with cancer: application to colorectal cancer. BMC Syst. Biol. 2011, 5:35.
78. Ohata N., Ito S., Yoshida A., Kunisada T., Numoto K., Jitsumori Y., Kanzaki H., Ozaki T., Shimizu K., Ouchida M. Highly frequent allelic loss of chromosome 6q16-23 in osteosarcoma: involvement of cyclin C in osteosarcoma. Int. J. Mol. Med. 2006, 18:1153-1158.
79. Osherovich L. CDK8 is enough in colorectal cancer. SciBX 2008, 1:5-7.
80. Ren S., Rollins B.J. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 2004, 117:239-251.
81. Rovnak J., Quackenbush S.L. Walleye dermal sarcoma virus cyclin interacts with components of the mediator complex and the RNA polymerase II holoenzyme. J. Virol. 2002, 76:8031-8039.
82. Russo A.A., Jeffrey P.D., Pavletich N.P. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 1996, 3:696-700.
83. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993, 234:779-815.
84. Samuelsen C.O., Baraznenok V., Khorosjutina O., Spahr H., Kieselbach T., Holmberg S., Gustafsson C.M. TRAP230/ARC240 and TRAP240/ARC250 Mediator subunits are functionally conserved through evolution. Proc. Natl. Acad. Sci. USA 2003, 100:6422-6427.
85. Sato S., Tomomori-Sato C., Parmely T.J., Florens L., Zybailov B., Swanson S.K., Banks C.A., Jin J., Cai Y., Washburn M.P., Conaway J.W., Conaway R.C. A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Mol. Cell 2004, 14:685-691.
86. Schneider E.V., Bottcher J., Blaesse M., Neumann L., Huber R., Maskos K. The structure of CDK8/CycC implicates specificity in the CDK/Cyclin family and reveals interaction with a deep pocket binder. J. Mol. Biol. 2011, 412:251-266.
87. Seo J.O., Han S.I., Lim S.C. Role of CDK8 and beta-catenin in colorectal adenocarcinoma. Oncol. Rep. 2010, 24:285-291.
88. Shahi P., Gulshan K., Näär A.M., Moye-Rowley W.S. Differential roles of transcriptional mediator subunits in regulation of multidrug resistance gene expression in Saccharomyces cerevisiae. Mol. Biol. Cell 2010, 21:2469-2482.
89. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
90. Sheffer M., Bacolod M.D., Zuk O., Giardina S.F., Pincas H., Barany F., Paty P.B., Gerald W.L., Notterman D.A., Domany E. Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc. Natl. Acad. Sci. USA 2009, 106:7131-7136.
91. Simmerling C., Strockbine B., Roitberg A.E. All-atom structure prediction and folding simulations of a stable protein. J. Am. Chem. Soc. 2002, 124:11258-11259.
92. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., Zhang J., Soden R., Hayakawa M., Kreiman G., Cooke M.P., Walker J.R., Hogenesch J.B. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 2004, 101:6062-6067.
93. Taatjes D.J. The human Mediator complex: a versatile, genome-wide regulator of transcription. Trends Biochem. Sci. 2010, 35:315-322.
94. Taatjes D.J., Näär A.M., Andel F., Nogales E., Tjian R. Structure, function, and activator-induced conformations of the CRSP coactivator. Science 2002, 295:1058-1062.
95. Takahashi H., Parmely T.J., Sato S., Tomomori-Sato C., Banks C.A., Kong S.E., Szutorisz H., Swanson S.K., Martin-Brown S., Washburn M.P., Florens L., Seidel C.W., Lin C., Smith E.R., Shilatifard A., Conaway R.C., Conaway J.W. Human Mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 2011, 146:92-104.
96. Takaki T., Echalier A., Brown N.R., Hunt T., Endicott J.A., Noble M.E.M. The structure of CDK4/cyclin D3 has implications for models of CDK activation. Proc. Natl. Acad. Sci. USA 2009, 106:4171-4176.
97. Tansey W.P. Transcriptional activation: risky business. Genes Dev. 2001, 15:1045-1050.
98. Tassan J.P., Jaquenoud M., Leopold P., Schultz S.J., Nigg E.A. Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc. Natl. Acad. Sci. USA 1995, 92:8871-8875.
99. Townsley F.M., Cliffe A., Bienz M. Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function. Nat. Cell Biol. 2004, 6:626-633.
100. Tsafrir D., Bacolod M., Selvanayagam Z., Tsafrir I., Shia J., Zeng Z., Liu H., Krier C., Stengel R.F., Barany F., Gerald W.L., Paty P.B., Domany E., Notterman D.A. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res. 2006, 66:2129-2137.
101. van de Peppel J., Kettelarij N., van Bakel H., Kockelkorn T.T., van Leenen D., Holstege F.C. Mediator expression profiling epistasis reveals a signal transduction pathway with antagonistic submodules and highly specific downstream targets. Mol. Cell 2005, 19:511-522.
102. van Delft F.W., Horsley S., Colman S., Anderson K., Bateman C., Kempski H., Zuna J., Eckert C., Saha V., Kearney L., Ford A., Greaves M. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia. Blood 2011, 117:6247-6254.
103. Velmurugan B., Gangar S.C., Kaur M., Tyagi A., Deep G., Agarwal R. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm. Res. 2010, 27:2085-2097.
104. Westerling T., Kuuluvainen E., Makela T.P. Cdk8 is essential for preimplantation mouse development. Mol. Cell. Biol. 2007, 27:6177-6182.
105. Wu S.Y., McNae I., Kontopidis G., McClue S.J., McInnes C., Stewart K.J., Wang S., Zheleva D.I., Marriage H., Lane D.P., Taylor P., Fischer P.M., Walkinshaw M.D. Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop. Structure 2003, 11:399-410.
106. Yang S., Jeung H.C., Jeong H.J., Choi Y.H., Kim J.E., Jung J.J., Rha S.Y., Yang W.I., Chung H.C. Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer. Genomics 2007, 89:451-459.
107. Ye X., Zhu C., Harper J.W. A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. Proc. Natl. Acad. Sci. USA 2001, 98:1682-1686.
108. Yoda A., Kouike H., Okano H., Sawa H. Components of the transcriptional Mediator complex are required for asymmetric cell division in C. elegans. Development 2005, 132:1885-1893.
109. Yudkovsky N., Ranish J.A., Hahn S. A transcription reinitiation intermediate that is stabilized by activator. Nature 2000, 408:225-229.